Article 11 Feb 2020 "Misleading" To Suggest A Biosimilar Is Inferior, FDA Draft Guidance Warns United States Healthcare
Article 05 Feb 2020 FDA Issues Draft Guidance Regarding "Sameness" For Orphan Drug Gene Therapies United States Healthcare
Article 05 Jun 2019 FDA Guidance May Ease Path To Biosimilar Interchangeability United States Healthcare